This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pfeffer, M. Articles by De Menezes, J. P. Search for Related Content PubMed PubMed Citation Articles by Pfeffer, M. Articles by De Menezes, J. P.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 February; 11(2): 331-338
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Comparative Human Oral Clinical Pharmacology of Cefadroxil, Cephalexin, and Cephradine

¹ Bristol-Myers Co., Inc., New York, New York 10022

ABSTRACT

At equivalent oral doses, cefadroxil has a longer serum half-life, slower urinary excretion rate, greater area under the serum level versus time curve than cephalexin or cephradine, and peak serum concentrations that are 75 to 80% those of cephalexin. The calculated, apparent in vivo volume of distribution of cefadroxil is greater than that of cephalexin. These properties infer greater persistence of cefadroxil in serum and urine and more prolonged in vivo bacterial exposure to cefadroxil than to cephalexin or cephradine. Neither cefadroxil nor cephalexin demonstrates drug accumulation on repeated administration. The serum levels achieved by cefadroxil are unaffected by food. The pharmacokinetic properties of cefadroxil are supportive of the development of clinical efficacy data which could indicate that cefadroxil could be administered at 12-h intervals.

¹ Address reprint requests to: P.O. Box 657, Syracuse, NY 13201.